SANDRI, Gilda
 Distribuzione geografica
Continente #
EU - Europa 11.435
NA - Nord America 4.508
AS - Asia 1.199
SA - Sud America 30
AF - Africa 20
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 17.207
Nazione #
IT - Italia 9.120
US - Stati Uniti d'America 4.432
GB - Regno Unito 1.013
SG - Singapore 389
SE - Svezia 283
CN - Cina 282
DE - Germania 235
HK - Hong Kong 194
FR - Francia 168
UA - Ucraina 159
TR - Turchia 144
FI - Finlandia 90
CA - Canada 59
BG - Bulgaria 57
IE - Irlanda 52
NL - Olanda 48
ES - Italia 41
ID - Indonesia 41
CH - Svizzera 35
IN - India 29
BE - Belgio 28
JP - Giappone 23
VN - Vietnam 20
MY - Malesia 18
PL - Polonia 15
RO - Romania 15
BR - Brasile 13
IR - Iran 13
MT - Malta 13
CZ - Repubblica Ceca 12
AR - Argentina 9
AU - Australia 9
KR - Corea 9
RU - Federazione Russa 9
LT - Lituania 8
BZ - Belize 7
GR - Grecia 7
NO - Norvegia 7
IL - Israele 6
MA - Marocco 6
MX - Messico 6
PH - Filippine 6
CO - Colombia 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
GT - Guatemala 4
MK - Macedonia 4
PT - Portogallo 4
TW - Taiwan 4
ZA - Sudafrica 4
BD - Bangladesh 3
DZ - Algeria 3
PK - Pakistan 3
TH - Thailandia 3
VE - Venezuela 3
AT - Austria 2
DK - Danimarca 2
EU - Europa 2
LV - Lettonia 2
SM - San Marino 2
SS - ???statistics.table.value.countryCode.SS??? 2
SY - Repubblica araba siriana 2
TZ - Tanzania 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BY - Bielorussia 1
HU - Ungheria 1
IQ - Iraq 1
LB - Libano 1
MD - Moldavia 1
MM - Myanmar 1
SA - Arabia Saudita 1
TN - Tunisia 1
YE - Yemen 1
Totale 17.207
Città #
Southend 872
Rome 771
Milan 697
Santa Clara 474
Fairfield 428
Chandler 408
Singapore 308
Ashburn 299
Woodbridge 258
Jacksonville 249
Houston 228
Naples 228
Bologna 226
Turin 208
Florence 204
Nyköping 199
Dearborn 196
Hong Kong 188
Ann Arbor 180
Wilmington 163
Bari 151
Seattle 143
Parma 128
Cambridge 111
Catania 91
Izmir 91
Modena 87
Genoa 83
Palermo 81
Cagliari 69
Beijing 64
Princeton 64
San Diego 59
Brescia 58
Verona 58
Sofia 55
Helsinki 54
Padova 53
Trento 46
Eugene 44
New York 40
Pescara 40
Reggio Emilia 40
Rimini 40
Jakarta 38
Trieste 37
Bremen 35
Livorno 35
Des Moines 33
Shanghai 33
Redwood City 32
Ottawa 29
Vicenza 28
London 26
Dublin 25
Salerno 25
Boardman 24
Valencia 24
Perugia 23
Monza 22
Brussels 21
Venice 21
Ancona 20
Frankfurt am Main 20
Messina 20
Falls Church 19
Munich 19
Treviso 19
Pavia 18
Bergamo 17
Napoli 17
Toronto 17
Cosenza 16
San Mateo 16
Cesena 15
Orta di Atella 15
Reggio Calabria 15
Taranto 15
Caserta 14
Novara 14
Piacenza 14
Pisa 14
Dong Ket 13
Los Angeles 13
Norwalk 13
Paris 13
Udine 13
Mascalucia 12
Acerra 11
Eboli 11
Lecco 11
Nanjing 11
Sarno 11
Busto Arsizio 10
Calcinaia 10
Cassino 10
Dallas 10
Foggia 10
Lucca 10
San Benedetto del Tronto 10
Totale 9.581
Nome #
Farmaci biologici e rischio oncologico 2.873
L’infezione da papilloma virus umano (HPV) nei pazienti con artrite reumatoide trattati con farmaci biologici 2.834
Tempi di sospensione dei farmaci biologici nello switch terapeutico e nella programmazione degli interventi chirurgici 2.441
Farmaci biologici e infezione tubercolare 375
Farmaci biologici e tematiche relative alla cardiopatia ischemica e all’insufficienza cardiaca 291
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 284
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 272
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 232
The discrepancy between clinical and ultrasonographic remission in rheumatoid arthritis is not related to therapy or autoantibody status. 224
La legislazione del dolore e la sua applicazione in Italia: pregi e difetti 219
Biological Therapy and Risk of Malignancies: A Literature Review 217
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 215
Large Vessel Vasculitis Occurring in Rheumatoid Arthritis Patient under Anti-TNF Therapy 204
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report. 171
EXPERIMENTAL USE OF 3D PRINTING TECHNOLOGY FOR THE CONSTRUCTION OF DEVICES AS INTEGRATION OF OCCUPATIONAL THERAPY INTERVENTION WITH RHEUMATOID ARTHRITIS PATIENTS (RA) 170
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 163
Cryoglobulin evaluation: analysis of intra-laboratory and inter-laboratory variability 162
Salivary 1H-NMR Metabolomics in Primary Sjögren Syndrome. Preliminary Results of a Pilot Case-Control Study 162
L’uso dei farmaci biologici durante la gravidanza e l’allattamento 159
Beyond cat scratch disease: a case report of bartonella infection mimicking vasculitic disorder 158
Ultrasonography in the diagnosis and management of patients with inflammatory arthritides 157
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 150
Non-Hodgkin Lymphoma in Psoriatic Arthritis Treated with Sequential, Multiple Anti-TNF-α Agents: A Case Report 148
Non HCV-related mixed cryoglobulinemia 148
ANTI - TUMOR NECROSIS FACTOR ALPHA (ANTI-TNF) DRUGS IN RHEUMATOID ARTHRITIS: COMPARISON ON DISEASE MANAGEMENT BEFORE AND AFTER THE INTRODUCTION OF THESE BIOLOGICAL DRUGS IN MODENA, ITALY 146
Sanitary costs of osteoarthritis 144
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 139
PREVALENCE OF ULTRASOUND ABNORMALITIES IN PATIENTS WITH PSORIATIC ARTHRITIS IN A CLINICAL PHASE OF MINIMAL DISEASE ACTIVITY UNDER ANTI-TNF TREATMENT 139
The prevalence of asymptomatic early sacroiliitis in Crohn’s disease patients: The single experience of an Italian tertiary care centre 138
ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA): THE RELATIONSHIP BETWEEN SEX, AGE AND ANTIGENIC SPECIFICITIES 137
HCV associated cryoglobulinemic vasculitis 137
Immunodeficiency and autoimmune phenomena in female hyper-IgM syndrome 136
Indicazioni chirurgiche alla artrodesi totale di polso nei pazienti affetti da artrite reumatoide. 134
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 134
Le crioglobuline miste: epidemiologia, clinica ed eziopatogenesi. Contributo personale. 133
UTILITY OF A SELF ADMINISTERED QUESTIONNAIRE AS A TOOL FOR SCREENING JOINT INVOLVEMENT UNDERWAY PSORIASIS 132
EULAR guidelines on ANCA-associated vasculitis in the real life 131
COMPLEMENT DEPLETION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB: A MARKER OF CLINICAL EFFICACY? 128
The New Test for Monitoring Infliximab Therapy: From Laboratory to Clinical Practice 127
Efficacia e sicurezza delle vaccinazioni anti-influenza e anti-pneumococco nei pazienti con artrite reumatoide trattati con farmaci biologici 119
RETENTION RATE OF ADALIMUMAB AND ABP 501 IN THE TREATMENT OF A LARGE COHORT OF PATIENTS WITH INFLAMMATORY ARTHRITIS: A REAL LIFE RETROSPECTIVE ANALYSIS 119
On- and off-label use of rituximab in rheumatic diseases 119
Does early arthritis clinic organisation improve outcomes? What evidence is there? A systematic review 115
Detection of autoimmunity in early primary Epstein-Barr virus infection by Western blot analysis 114
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers 114
EXPERIENCE OF MULTIDISCIPLINARY TEAM FOR COMPLEX HAND FUNCTION PROBLEMS AT THE RHEUMATOLOGY OUTPATIENT CLINIC OF MODENA 108
NATURAL HISTORY OF CRYOGLOBULINEMIA FROM 2000 TO 2018 FROM THE LABORATORY POINT OF VIEW: AN ANALYSIS OF CRYOGLOBULIN CHARACTERISTICS IN A SINGLE CENTER. 103
Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis 102
Patient characteristics of HCV-negative mixed cryoglobulinemia (MC) in Italy and Holland 101
Farmaci biologici ed epatiti da virus B e C 100
Frequency and Results of Cryoglobulin Retesting in 4,963 Patients: Comment on the Article by Kolopp-Sarda et al 99
IS THERE A DISSOCIATION BETWEEN CLINICAL REMISSION AND ULTRASONOGRAPHIC ASSESSMENT IN RHEUMATOID ARTHRITIS? 98
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study 87
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study (2023-02-07) 83
Ultrasonographic and clinical assessment of peripheral enthesitis and arthritis in an Italian cohort of inflammatory bowel disease patients 83
Diagnosi di crioproteinemia: preziosa collaborazione tra laboratorio e clinica per la corretta gestione di una patologia rara 82
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 77
Endothelial Dysfunction in Acute Hepatic Porphyrias 67
Early Occupational Therapy Intervention: Patients’ Occupational Needs 64
Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability (Modern Pathology, (2020), 33, 7, (1398-1409), 10.1038/s41379-020-0497-0) 60
The management of large vessel vasculitides 57
Metabolic Profile of Whole Unstimulated Saliva in Patients with Sjögren's Syndrome 55
PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability 55
Apremilast retention rate in clinical practice: observations from an Italian multi-center study 53
Promising use of filgotinib in patients affected by systemic sclerosis: Preliminary data from a case series of 5 patients 47
Analysis of cryoproteins with a focus on cryofibrinogen: a study on 103 patients 37
Buerger's disease or thromboangiitis obliterans: description of two cases 35
Baseline Ultrasound Assessment Improves the Response to Apremilast in Patients with Psoriatic Arthritis: Results from a Multicentre Study 33
Reazioni cutanee e terapia con anti-TNF-α 33
THE PREDICTIVE ROLE OF THE TAPSE/sPAP RATIO FOR CARDIOVASCULAR EVENTS AND MORTALITY IN SYSTEMIC SCLEROSIS COMPLICATED BY PULMONARY HYPERTENSION 29
Cryoproteinemia: new frontiers for clinicians and the laboratory 29
Cryofibrinogen: A possibile risk factor in systemic sclerosis 29
Assessing hand grasp in patients with systemic sclerosis using the 16-grasp test: Preliminary results from a multidisciplinary study group 26
ORAL MANIFESTATIONS IN SYSTEMICSCLEROSIS: CLINICAL EVALUATION OF APERSONAL CASE SERIES OF 13 SCLERODERMAPATIENTS 25
EFFICACY OF CERTOLIZUMAB PEGOL FOR DISEASE CONTROL OF PATIENTS AFFECTED BY ENTEROPATHIC SPONDYLARTHRITIS FOLLOWED BY THE JOINT GASTRO-RHEUMATOLOGICAL CLINIC 24
Analysis of survival rate and persistence predictors of baricitinib in real-world data from a large cohort of rheumatoid arthritis patients 21
SAFETY AND EFFICACY OF INTRAVENOUS ILOPROST IN THE TREATMENT AND PREVENTION OF SCLERODERMA-RELATED DIGITAL ULCERS 20
A consensus-based approach on the management of patients with both psoriasis and psoriatic arthritis in the dermatological and rheumatological settings in Italy: The ADOI PSO-Amore Project 18
Factors associated of long-term retention rate of Janus kinase inhibitors in a multi-failure rheumatoid arthritis population 17
ACCERTAMENTO DELLA DISABILITÀ NELLE MALATTIE REUMATOLOGICHE (EX L.R. N.4 DEL 19 FEBBRAIO 2008) PROPOSTA DI PROTOCOLLO ORGANIZZATIVO 17
Upadacitinib: One More Option in the Treatment of Patients with Rheumatoid Arthritis and Crohn's Disease 17
CYCLING VS SWAP TNFi AND IL17i IN PSORIATIC ARTHRITIS: RESULTS FROM THE BIRRA RETROSPECTIVE OBSERVATIONAL STUDY 16
L’IPERTENSIONE POLMONARE: DALLE NUOVE LINEE GUIDA ALLA PRATICA CLINICA 16
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study 16
Influence of safety warnings on the prescribing attitude of JAK 2inhibitors for rheumatoid arthritis in Italy 16
PROBABILITÀ DI SIEROCONVERSIONE DEL TEST QUANTIFERON DURANTE LA TERAPIA BIOTECNOLOGICA: DATI PRELIMINARI DI UNO STUDIO RETROSPETTIVO CONDOTTO PRESSO L’ARTHRITIS CLINIC DELL’AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA 15
CONFRONTO TRA STRATEGIE DI TERAPIA AVANZATA DI 2° E 3° LINEA NELLA ARTRITE PSORIASICA: RISULTATI PRELIMINARI DALLO STUDIO OSSERVAZIONE RETROSPETTIVO BIRRA 15
Cycling versus swapping strategieswith TNF-α inhibitors and IL-17 inhibitors in psoriatic arthritis in clinical practice 14
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study 13
Risankizumab e Upadacitinib nel Trattamento dell'Artrite Psoriasica: Meccanismi Diversi, Obiettivo Comune 13
Therapeutic Effects of Apremilast on Enthesitis and Dactylitis in Real Clinical Setting: An Italian Multicenter Study 13
The importance of body image and aesthetic medicine in systemic sclerosis 12
JANUS KINASES INHIBITORS IN CLINICAL PRACTICE IN ITALY. RESULTS FROM A SINGLE CENTER EXPERIENCE 12
Residual inflammation in psoriatic arthritis patients in stable minimal disease activity 11
DIFFERENCES BETWEEN SELECTIVE AND UNSELECTIVE JAKi: RESULTS FROM A MULTICENTRIC, REAL LIFE STUDY CARRIED OUT ON PATIENTS WITH RA 10
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension 8
POS0604 JAKi’S SURVIVAL RATE AND PREDICTORS OF DISCONTINUATION IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS 8
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis 7
Totale 17.370
Categoria #
all - tutte 48.158
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.158


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.123 0 0 0 0 128 212 226 162 153 99 92 51
2020/20211.566 175 82 106 90 165 121 170 155 114 209 94 85
2021/20221.414 65 123 69 109 54 90 59 87 212 72 277 197
2022/20232.719 184 186 171 161 194 293 152 259 313 177 312 317
2023/20245.535 318 249 393 460 512 413 562 550 273 595 618 592
2024/20252.966 570 415 411 676 894 0 0 0 0 0 0 0
Totale 17.370